SG Americas Securities, LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 211 filers reported holding BEAM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$363
-27.1%
15,098
-7.2%
0.00%
-33.3%
Q1 2023$498
+203.7%
16,277
+288.8%
0.01%
+200.0%
Q4 2022$164
-100.0%
4,187
-46.1%
0.00%
-60.0%
Q3 2022$370,000
-66.1%
7,765
-72.4%
0.01%
-58.3%
Q2 2022$1,091,000
+238.8%
28,183
+401.7%
0.01%
+500.0%
Q1 2022$322,000
-72.3%
5,617
-61.5%
0.00%
-66.7%
Q4 2021$1,164,000
-35.3%
14,602
-29.3%
0.01%
-25.0%
Q3 2021$1,798,000
+14.2%
20,667
+69.0%
0.01%
+14.3%
Q2 2021$1,574,000
+79.7%
12,227
+11.7%
0.01%
+40.0%
Q1 2021$876,000
+356.2%
10,946
+59.4%
0.01%
+150.0%
Q2 2020$192,0006,8660.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders